Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.Appl Biochem Biotechnol. 2012 Nov; 168(5):1153-62.AB
Abstract
A newly synthesized series of chalcone derivatives containing pyrazole rings were synthesized and evaluated for their cytotoxic activities in vitro against several human cancer cell lines. Most of the prepared compounds showed potential cytotoxicity against human breast cancer cell lines MCF-7, HEPG-2, and HCT-116. Also the compounds were evaluated as antimicrobial agents. The three compounds 3, 4, and 5 were proved to be better anticancer agents than the positive standard doxorubicin with IC50 values (4.7, 4.4, and 3.9 μg/ml) against the same human cancer cell lines, whereas compounds 5 and 6 showed the most active antimicrobial compounds in comparison to the other chalcones.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
22948604
Citation
Mohamed, Magda F., et al. "Synthesis and Biological Evaluation of a Novel Series of Chalcones Incorporated Pyrazole Moiety as Anticancer and Antimicrobial Agents." Applied Biochemistry and Biotechnology, vol. 168, no. 5, 2012, pp. 1153-62.
Mohamed MF, Mohamed MS, Shouman SA, et al. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents. Appl Biochem Biotechnol. 2012;168(5):1153-62.
Mohamed, M. F., Mohamed, M. S., Shouman, S. A., Fathi, M. M., & Abdelhamid, I. A. (2012). Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents. Applied Biochemistry and Biotechnology, 168(5), 1153-62. https://doi.org/10.1007/s12010-012-9848-8
Mohamed MF, et al. Synthesis and Biological Evaluation of a Novel Series of Chalcones Incorporated Pyrazole Moiety as Anticancer and Antimicrobial Agents. Appl Biochem Biotechnol. 2012;168(5):1153-62. PubMed PMID: 22948604.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
AU - Mohamed,Magda F,
AU - Mohamed,Mervat S,
AU - Shouman,Samia A,
AU - Fathi,Mohamed M,
AU - Abdelhamid,Ismail Abdelshafy,
Y1 - 2012/09/05/
PY - 2012/01/23/received
PY - 2012/08/15/accepted
PY - 2012/9/6/entrez
PY - 2012/9/6/pubmed
PY - 2013/6/1/medline
SP - 1153
EP - 62
JF - Applied biochemistry and biotechnology
JO - Appl Biochem Biotechnol
VL - 168
IS - 5
N2 - A newly synthesized series of chalcone derivatives containing pyrazole rings were synthesized and evaluated for their cytotoxic activities in vitro against several human cancer cell lines. Most of the prepared compounds showed potential cytotoxicity against human breast cancer cell lines MCF-7, HEPG-2, and HCT-116. Also the compounds were evaluated as antimicrobial agents. The three compounds 3, 4, and 5 were proved to be better anticancer agents than the positive standard doxorubicin with IC50 values (4.7, 4.4, and 3.9 μg/ml) against the same human cancer cell lines, whereas compounds 5 and 6 showed the most active antimicrobial compounds in comparison to the other chalcones.
SN - 1559-0291
UR - https://www.unboundmedicine.com/medline/citation/22948604/Synthesis_and_biological_evaluation_of_a_novel_series_of_chalcones_incorporated_pyrazole_moiety_as_anticancer_and_antimicrobial_agents_
L2 - https://dx.doi.org/10.1007/s12010-012-9848-8
DB - PRIME
DP - Unbound Medicine
ER -